NL300856I2 - - Google Patents

Download PDF

Info

Publication number
NL300856I2
NL300856I2 NL300856C NL300856C NL300856I2 NL 300856 I2 NL300856 I2 NL 300856I2 NL 300856 C NL300856 C NL 300856C NL 300856 C NL300856 C NL 300856C NL 300856 I2 NL300856 I2 NL 300856I2
Authority
NL
Netherlands
Prior art keywords
nucleotides
splice
polynucleotide
altered
replaced
Prior art date
Application number
NL300856C
Other languages
English (en)
Original Assignee
Molmed Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molmed Spa filed Critical Molmed Spa
Publication of NL300856I2 publication Critical patent/NL300856I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
NL300856C 2004-06-18 2016-12-29 NL300856I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0413702.2A GB0413702D0 (en) 2004-06-18 2004-06-18 Thymidine kinase
PCT/IB2005/002358 WO2005123912A2 (en) 2004-06-18 2005-06-17 Thymidine kinase

Publications (1)

Publication Number Publication Date
NL300856I2 true NL300856I2 (nl) 2017-04-20

Family

ID=32750189

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300856C NL300856I2 (nl) 2004-06-18 2016-12-29

Country Status (21)

Country Link
US (5) US8357788B2 (nl)
EP (1) EP1781789B1 (nl)
JP (1) JP5091669B2 (nl)
KR (1) KR101337210B1 (nl)
CN (1) CN101010428B (nl)
AT (1) ATE520779T1 (nl)
AU (1) AU2005254807B2 (nl)
CA (1) CA2569304C (nl)
CY (2) CY1111925T1 (nl)
DK (1) DK1781789T3 (nl)
ES (1) ES2372022T3 (nl)
GB (1) GB0413702D0 (nl)
HK (1) HK1097881A1 (nl)
HU (1) HUS1600064I1 (nl)
IL (2) IL179660A (nl)
LT (1) LTC1781789I2 (nl)
NL (1) NL300856I2 (nl)
PL (1) PL1781789T3 (nl)
PT (1) PT1781789E (nl)
SI (1) SI1781789T1 (nl)
WO (1) WO2005123912A2 (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
US20140248695A1 (en) 2011-10-05 2014-09-04 MolMed, S.p.A. Viral Vectors Purification System
WO2019132596A1 (ko) * 2017-12-28 2019-07-04 주식회사 바이오녹스 안전성 및 항암효과가 개선된 종양 용해 바이러스
US11157042B1 (en) 2018-03-28 2021-10-26 Douglas Patton Systems and methods for interaction of wearable communication devices
WO2019229109A1 (en) 2018-05-30 2019-12-05 Glycostem Therapeutics B.V. Car nk cells
US20220202885A1 (en) * 2019-06-27 2022-06-30 Bionoxx Inc. Oncolytic virus with improved safety and anticancer effects

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69033975T2 (de) 1989-01-23 2002-10-02 Chiron Corp Rekombinanttherapien für Infektionen und hyperproliferative Störungen
JP2752788B2 (ja) 1989-01-23 1998-05-18 カイロン コーポレイション 感染および過剰増殖障害の為の組換え療法
US5631236A (en) 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
FR2712603B1 (fr) 1993-11-18 1996-02-09 Centre Nat Rech Scient Virus recombinants, préparation et utilisation en thérapie génique.
CA2189543A1 (en) 1994-05-02 1995-11-09 Lawrence A. Loeb Thymidine kinase mutants
FR2751988B1 (fr) 1996-08-01 1998-09-11 Rhone Poulenc Rorer Sa Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
BR9707483A (pt) * 1996-02-09 1999-04-06 Rhone Poulenc Rorer Sa Sequência de ácidos nucléicos que codificam para uma timidina quinase variante de uma timidina quinase selvagem variante de uma timidina quinase do vírus do herpes simplex de tipo 1 veículo de expressão vetor e composição farmacêutica
FR2744731B1 (fr) 1996-02-09 1998-05-22 Rhone Poulenc Rorer Sa Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
EP0954222A4 (en) 1996-04-10 2003-01-15 Univ Southern California GENE THERAPY FOR PROLIFERATIVE VITREORETINOPATHY
EP2298350A3 (en) 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
ATE374247T1 (de) 1997-10-14 2007-10-15 Darwin Molecular Corp Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
GB0008966D0 (en) * 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
CN1273587C (zh) * 2002-06-05 2006-09-06 上海新世界基因技术开发有限公司 疱疹病毒胸苷激酶突变体及其应用
DE50213745D1 (de) 2002-12-09 2009-09-17 Celltech Gmbh Biotechnologie Verbesserte retrovirale Vektoren für die Gentherapie
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase

Also Published As

Publication number Publication date
IL213084A0 (en) 2011-07-31
EP1781789A2 (en) 2007-05-09
US20150231275A1 (en) 2015-08-20
KR101337210B1 (ko) 2013-12-06
US20130028876A1 (en) 2013-01-31
ES2372022T3 (es) 2012-01-13
KR20070032786A (ko) 2007-03-22
CY2016054I1 (el) 2017-07-12
CN101010428A (zh) 2007-08-01
LTC1781789I2 (lt) 2018-10-10
US8642311B2 (en) 2014-02-04
LTPA2016047I1 (lt) 2017-01-25
CA2569304C (en) 2014-08-12
ATE520779T1 (de) 2011-09-15
CY1111925T1 (el) 2015-11-04
SI1781789T1 (sl) 2012-03-30
CY2016054I2 (el) 2017-07-12
HUS1600064I1 (hu) 2017-02-28
EP1781789B1 (en) 2011-08-17
IL179660A0 (en) 2007-05-15
JP5091669B2 (ja) 2012-12-05
US20140178345A1 (en) 2014-06-26
PL1781789T3 (pl) 2011-12-30
AU2005254807A1 (en) 2005-12-29
US8357788B2 (en) 2013-01-22
CA2569304A1 (en) 2005-12-29
IL179660A (en) 2012-12-31
WO2005123912A2 (en) 2005-12-29
US10155052B2 (en) 2018-12-18
JP2008502342A (ja) 2008-01-31
PT1781789E (pt) 2011-10-20
US9005945B2 (en) 2015-04-14
US10314925B2 (en) 2019-06-11
GB0413702D0 (en) 2004-07-21
WO2005123912A3 (en) 2006-05-04
US20190070312A1 (en) 2019-03-07
HK1097881A1 (en) 2007-07-06
CN101010428B (zh) 2013-10-02
AU2005254807B2 (en) 2011-08-18
US20090130069A1 (en) 2009-05-21
DK1781789T3 (da) 2011-11-28

Similar Documents

Publication Publication Date Title
HUS1600064I1 (hu) Timidin kináz
GB2457402A (en) Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators
WO2010018577A3 (en) Data entry system
BRPI0820500A2 (pt) Variantes de alfa-amilase de bacillus sp. Ts-23 com propriedades alteradas
AR056256A1 (es) Plantas resistentes al estres
DE602007006591D1 (de) System unter Benutzung von mehreren Antennen zur Übertragung des Kontrollkanals
TW200630362A (en) (2-carboxamido)(3-amino)thiophene compounds
UA115022C2 (uk) Трансгенна рослина, яка містить нуклеїнову кислоту, що має виділену нуклеотидну послідовність, яка кодує модифіковану інтеїном ксиланазу
CY1111486T1 (el) Μιμητικα αντισωματα (mimetibodies) δεσμευμενα με υποδοχεα μελανοκορτινης, συνθεσεις, μεθοδοι και χρησεις
NO20100724L (no) Ledende sementformulering og anvendelse av denne i en bronn
EP1625567A4 (en) SYSTEM FOR USING THE WHITE KEYS OF MUSIC INSTRUMENT KEYBOARDS FOR SELECTED RANGES
TW200834332A (en) System including bus matrix
ATE438726T1 (de) Modulation der anzahl von pflanzenzellen
TW200604604A (en) Light guide plate and backlight system
ITTO20050108A1 (it) Trasmissione idrostatica a variazione continua.
ATE543828T1 (de) Heteropolynukleotid-duplexe mit purin-purin- paarung
TW200834278A (en) Multiplier-divider with error compensation function
TW200833903A (en) Construction method of combining geogrid rack and concrete
GB202208604D0 (en) Single-molecule RNA structure profiling
WO2008037924A3 (fr) Nouvel oligonucleotide marque
DE50307207D1 (de) Verwendung von 5-substituierten nukleosiden zur verstärkung der apoptotischen wirkung von zytostatika
DK2254950T3 (da) 1,3-thiazolyl-azo-farvestoffer, deres frembringelse og anvendelse
TR200704119A2 (tr) Bir toprak işleme makinası
Mori Engineering Education
ATE486891T1 (de) Gewebsspezifische expression